Hoffmann Diane, Schwartz Jack
Am J Law Med. 2016;42(1):53-84. doi: 10.1177/0098858816644715.
This Article offers a thorough analysis of an important public health issue, namely how to confront the growing problem of deceptive claims regarding foods and dietary supplements, including increasingly prevalent but unverifiable claims. The authors call for the creation of a limited private right of action under the Federal Trade Commission (FTC) Act for deceptive health-related claims for these products. The proposal responds to the growing market for these products and the inadequacy of current laws and enforcement actions to prevent such claims. In crafting the limited private right of action, the authors attempt to enhance consumer protection without undermining federal agency primacy in enforcement. The Article ends with an appendix setting forth proposed language for a statutory amendment to the FTC Act incorporating the authors' proposal.
本文对一个重要的公共卫生问题进行了全面分析，即如何应对食品和膳食补充剂方面日益增多的虚假宣传问题，包括越来越普遍但无法证实的宣传。作者呼吁根据《联邦贸易委员会（FTC）法》设立一项有限的私人诉讼权，以应对这些产品与健康相关的虚假宣传。该提议是针对这些产品不断增长的市场以及现行法律和执法行动在防止此类宣传方面的不足而提出的。在制定有限的私人诉讼权时，作者试图在不损害联邦机构执法首要地位的前提下加强消费者保护。本文末尾附有一个附录，列出了对《联邦贸易委员会法》进行法定修订的提议措辞，其中纳入了作者的提议。
